Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study).

Soroka S, Agharazii M, Donnelly S, Roy L, Muirhead N, Cournoyer S, MacKinnon M, Pannu N, Barrett B, Madore F, Tennankore K, Wilson JA, Hilton F, Sherman N, Wolter K, Orazem J, Feugère G.

Can J Kidney Health Dis. 2018 Nov 4;5:2054358118809104. doi: 10.1177/2054358118809104. eCollection 2018.

2.

Multiple sclerosis in pediatric patients in Slovenia.

Krajnc N, Oražem J, Rener-Primec Z, Kržan MJ.

Mult Scler Relat Disord. 2018 Feb;20:194-198. doi: 10.1016/j.msard.2018.01.026. Epub 2018 Jan 31.

PMID:
29414298
3.

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.

Wigal SB, Childress A, Berry SA, Belden H, Walters F, Chappell P, Sherman N, Orazem J, Palumbo D.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):690-699. doi: 10.1089/cap.2016.0177. Epub 2017 May 30.

4.

Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis.

Hopson S, Saverno K, Liu LZ, AL-Sabbagh A, Orazem J, Costantino ME, Pasquale MK.

J Manag Care Spec Pharm. 2016 Feb;22(2):122-30. doi: 10.18553/jmcp.2016.14261. Epub 2015 Dec 14.

5.

Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders.

Macedoni-Lukšič M, Gosar D, Bjørklund G, Oražem J, Kodrič J, Lešnik-Musek P, Zupančič M, France-Štiglic A, Sešek-Briški A, Neubauer D, Osredkar J.

Biol Trace Elem Res. 2015 Feb;163(1-2):2-10. doi: 10.1007/s12011-014-0121-6. Epub 2014 Sep 19.

PMID:
25234471
6.
7.

Epilepsy treatment in Rett syndrome.

Krajnc N, Župančič N, Oražem J.

J Child Neurol. 2011 Nov;26(11):1429-33. doi: 10.1177/0883073811408422. Epub 2011 Jun 2.

PMID:
21636780
8.

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators.

N Engl J Med. 2005 Jan 6;352(1):29-38.

9.

Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial.

Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman N, Mancia G.

Am J Hypertens. 2004 Dec;17(12 Pt 1):1135-42.

PMID:
15607620
10.

Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms.

Rosen RC, Seidman SN, Menza MA, Shabsigh R, Roose SP, Tseng LJ, Orazem J, Siegel RL.

Int J Impot Res. 2004 Aug;16(4):334-40.

PMID:
14961048
11.
12.

Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial.

Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, Deriesthal H.

Urology. 2003 Sep;62(3):400-3.

PMID:
12946731
13.

A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease.

Relkin NR, Reichman WE, Orazem J, McRae T.

Dement Geriatr Cogn Disord. 2003;16(1):15-24.

PMID:
12714795
14.
15.

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

Neurology. 1998 May;50(5):1222-30.

PMID:
9595967
16.

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B.

Neurology. 1998 May;50(5):1214-21. Erratum in: Neurology 1998 Jul;51(1):332.

PMID:
9595966
17.

Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease.

Pettigrew LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR, Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski B.

J Clin Pharmacol. 1998 Mar;38(3):236-45.

PMID:
9549662
18.

Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Rigas JR, Francis PA, Miller VA, Tong WP, Roistacher N, Kris MG, Orazem JP, Young CW, Warrell RP Jr.

Cancer Chemother Pharmacol. 1995;35(6):483-8.

PMID:
7882456
19.

A nonparametric analysis of the transmission rate of human immunodeficiency virus from mother to infant.

Tsai WY, Goedert JJ, Orazem J, Landesman SH, Rubinstein A, Willoughby A, Gail MH.

Biometrics. 1994 Dec;50(4):1015-28.

PMID:
7786984
20.

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

Francis PA, Rigas JR, Kris MG, Pisters KM, Orazem JP, Woolley KJ, Heelan RT.

J Clin Oncol. 1994 Jun;12(6):1232-7.

PMID:
7911159
21.

Neoplastic transformation dose response of oncogene-transfected rat embryo cells by gamma rays or 6 MeV alpha particles.

Ling CC, Weiss H, Strauss A, Endlich B, Sheh Y, Wei JX, Orazem J.

Radiat Res. 1994 Apr;138(1):79-85.

PMID:
8146303
22.

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

Leibel SA, Heimann R, Kutcher GJ, Zelefsky MJ, Burman CM, Melian E, Orazem JP, Mohan R, LoSasso TJ, Lo YC, et al.

Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):55-65.

PMID:
7505776
23.

Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.

Rigas JR, Francis PA, Muindi JR, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP Jr.

J Natl Cancer Inst. 1993 Dec 1;85(23):1921-6.

PMID:
8230282
24.

Isoflurane versus fentanyl: hemodynamic effects in cancer patients treated with anthracyclines.

Thorne AC, Orazem JP, Shah NK, Matarazzo D, Dwyer D, Pierri MK, Hoskins WJ, Rubin SC, Bedford RF.

J Cardiothorac Vasc Anesth. 1993 Jun;7(3):307-11.

PMID:
8518377
25.

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E.

Cancer Res. 1993 May 15;53(10 Suppl):2379-85.

26.

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr.

Cancer Res. 1992 Dec 1;52(23):6619-23.

27.

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

Grant SC, Gralla RJ, Kris MG, Orazem J, Kitsis EA.

J Clin Oncol. 1992 Mar;10(3):484-98.

PMID:
1311028
28.

Medicaid versus state funding of community residences: impact on daily life of people with mental retardation.

O'Neill J, Brown M, Gordon W, Orazem J, Hoffman C, Schonhorn R.

Ment Retard. 1990 Jun;28(3):183-8.

PMID:
2195290
29.

Relationship among CT scans, neurological exam, and neuropsychological test performance in right-brain-damaged stroke patients.

Egelko S, Gordon WA, Hibbard MR, Diller L, Lieberman A, Holliday R, Ragnarsson K, Shaver MS, Orazem J.

J Clin Exp Neuropsychol. 1988 Oct;10(5):539-64.

PMID:
3225314

Supplemental Content

Loading ...
Support Center